期刊
CIRCULATION RESEARCH
卷 127, 期 8, 页码 1056-1073出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.120.316742
关键词
claudin-5; endothelium; junctional adhesion molecule A; tight junctions; vascular permeability
资金
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [18683, 21320]
- AIRC 5x1000 call Metastatic disease: the key unmet need in oncology of the MYNERVA project [21267]
- European Research Council [742922]
- Initial Training Networks BtRAIN [675619]
- CARIPLO (Cassa di Risparmio delle Provincie Lombarde) Foundation [2014-1038, 2016-0461]
- Italian Ministry of Health (Ricerca Finalizzata) [PE-2016-02362551]
- Telethon Foundation [GGP19202]
- IEO-CCM (Istituto Europeo di Oncologia-Centro Cardiologico Monzino) Foundation
- Umberto Veronesi Foundation
- Swedish Science Council
- Knut and Alice Wallenberg Foundation
- European Research Council (ERC) [742922] Funding Source: European Research Council (ERC)
Rationale: Intercellular tight junctions are crucial for correct regulation of the endothelial barrier. Their composition and integrity are affected in pathological contexts, such as inflammation and tumor growth. JAM-A (junctional adhesion molecule A) is a transmembrane component of tight junctions with a role in maintenance of endothelial barrier function, although how this is accomplished remains elusive. Objective: We aimed to understand the molecular mechanisms through which JAM-A expression regulates tight junction organization to control endothelial permeability, with potential implications under pathological conditions. Methods and Results: Genetic deletion of JAM-A in mice significantly increased vascular permeability. This was associated with significantly decreased expression of claudin-5 in the vasculature of various tissues, including brain and lung. We observed that C/EBP-alpha (CCAAT/enhancer-binding protein-alpha) can act as a transcription factor to trigger the expression of claudin-5 downstream of JAM-A, to thus enhance vascular barrier function. Accordingly, gain-of-function for C/EBP-alpha increased claudin-5 expression and decreased endothelial permeability, as measured by the passage of fluorescein isothiocyanate (FITC)-dextran through endothelial monolayers. Conversely, C/EBP-alpha loss-of-function showed the opposite effects of decreased claudin-5 levels and increased endothelial permeability. Mechanistically, JAM-A promoted C/EBP-alpha expression through suppression of beta-catenin transcriptional activity, and also through activation of EPAC (exchange protein directly activated by cAMP). C/EBP-alpha then directly binds the promoter of claudin-5 to thereby promote its transcription. Finally, JAM-A-C/EBP-alpha-mediated regulation of claudin-5 was lost in blood vessels from tissue biopsies from patients with glioblastoma and ovarian cancer. Conclusions: We describe here a novel role for the transcription factor C/EBP-alpha that is positively modulated by JAM-A, a component of tight junctions that acts through EPAC to up-regulate the expression of claudin-5, to thus decrease endothelial permeability. Overall, these data unravel a regulatory molecular pathway through which tight junctions limit vascular permeability. This will help in the identification of further therapeutic targets for diseases associated with endothelial barrier dysfunction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据